Brown, Christine E <br/><br/>
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.  [electronic resource] 

 -  The New England journal of medicine  12 2016 
 - 2561-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1610497  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Engineering<br/>Combined Modality Therapy<br/>Glioblastoma--therapy<br/>Humans<br/>Immunotherapy, Adoptive<br/>Interleukin-13 Receptor alpha2 Subunit<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--therapy<br/>Receptors, Antigen, T-Cell--therapeutic use